相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
AKR1C3 (type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase): Roles in malignancy and endocrine disorders
Trevor M. Penning
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Development of a Gram-Scale Synthesis of PBRM, an Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1
Rene Maltais et al.
ORGANIC PROCESS RESEARCH & DEVELOPMENT (2019)
Steroid sulphatase inhibition via aryl sulphamates: clinical progress, mechanism and future prospects
Barry V. L. Potter
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2018)
Pharmacokinetic profile of PBRM in rodents, a first selective covalent inhibitor of 17β-HSD1 for breast cancer and endometriosis treatments
Rene Maltais et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Selective estrogen receptor modulators (SERMs) and selective estrogen receptor degraders (SERDs) in cancer treatment
Hitisha K. Patel et al.
PHARMACOLOGY & THERAPEUTICS (2018)
Combined Biophysical Chemistry Reveals a New Covalent Inhibitor with a Low-Reactivity Alkyl Halide
Tang Li et al.
JOURNAL OF PHYSICAL CHEMISTRY LETTERS (2018)
Covalent inhibitors design and discovery
Stephane De Cesco et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Insight into the mode of action and selectivity of PBRM, a covalent steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type 1
Alexandre Trottier et al.
BIOCHEMICAL PHARMACOLOGY (2017)
IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients
Carlo Palmieri et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Targeted Covalent Inhibitors for Drug Design
Thomas A. Baillie
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Human dehydrogenase/reductase (SDR family) member 11 is a novel type of 17β-hydroxysteroid dehydrogenase
Satoshi Endo et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Sulfatase inhibitors for recidivist breast cancer treatment: A chemical review
Ramanpreet Shah et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health
Mark P. Thomas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
A chromatography/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume
Patrick Caron et al.
STEROIDS (2015)
Structure Based Design, Synthesis, and Evaluation of Potential Inhibitors of Steroid Sulfatase
E. V. Costa et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2014)
Discovery of a Non-Estrogenic Irreversible Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type 1 from 3-Substituted-16β-(m-carbamoylbenzyl)-estradiol Derivatives
Rene Maltais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Promiscuity and Selectivity in Covalent Enzyme Inhibition: A Systematic Study of Electrophilic Fragments
Christian Joest et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
A phase I dose escalation study to determine the optimal biological dose of irosustat, an oral steroid sulfatase inhibitor, in postmenopausal women with estrogen receptor-positive breast cancer
R. Charles Coombes et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
A Challenge for Medicinal Chemistry by the 17β-hydroxysteroid Dehydrogenase Superfamily: An Integrated Biological Function and Inhibition Study
S. -X. Lin et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Steroid derivatives as inhibitors of steroid sulfatase
Yaser A. Mostafa et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: A combined binding and cell study
Jiong Chen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Assessment of steroidogenesis and steroidogenic enzyme functions
Van Luu-The
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Estrogen biosynthesis, phase I and phase II metabolism, and action in endometrial cancer
Tea Lanišnik Rižner
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
Inhibition of dehydroepiandosterone sulfate action in androgen-sensitive tissues by EM-1913, an inhibitor of steroid sulfatase
Jenny Roy et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
The Discovery and Development of Selective Estrogen Receptor Modulators (SERMs) for Clinical Practice
Philipp Y. Maximov et al.
CURRENT CLINICAL PHARMACOLOGY (2013)
Steroid sulfatase inhibitors for estrogen- and androgen-dependent cancers
Atul Purohit et al.
JOURNAL OF ENDOCRINOLOGY (2012)
A New Nonestrogenic Steroidal Inhibitor of 17β-Hydroxysteroid Dehydrogenase Type I Blocks the Estrogen-Dependent Breast Cancer Tumor Growth Induced by Estrone
Diana Ayan et al.
MOLECULAR CANCER THERAPEUTICS (2012)
17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: Protein structures, functions, and recent progress in inhibitor development
Sandrine Marchais-Oberwinkler et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Steroid sulfatase inhibitors: A review covering the promising 2000-2010 decade
Rene Maltais et al.
STEROIDS (2011)
Crucial Role of 3-Bromoethyl in Removing the Estrogenic Activity of 17β-HSD1 Inhibitor 16β-(m-Carbamoylbenzyl)estradiol
Rene Maltais et al.
ACS MEDICINAL CHEMISTRY LETTERS (2011)
17 beta-Hydroxysteroid dehydrogenase inhibitors: a patent review
Donald Poirier
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Advances in Development of Inhibitors of 17β-Hydroxysteroid Dehydrogenases
Donald Poirier
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2009)
17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer
Agneta Jansson
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2009)
Estrone C15 derivatives-A new class of 17β-hydroxysteroid dehydrogenase type 1 inhibitors
Josef Messinger et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Relative involvement of three 17β-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors
Yannick Laplante et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Estradiol and estrone C-16 derivatives as inhibitors of type 1 17β-hydroxysteroid dehydrogenase:: Blocking of ER+ breast cancer cell proliferation induced by estrone
Yannick Laplante et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1
S. Gobec et al.
CURRENT MEDICINAL CHEMISTRY (2008)
New Cancer Drugs Targeting the Biosynthesis of Estrogens and Androgens
Donald Poirier
DRUG DEVELOPMENT RESEARCH (2008)
Design and validation of specific inhibitors of 17β-hydroxysteroid dehydrogenases for therapeutic application in breast and prostate cancer, and in endometriosis
Joanna M. Day et al.
ENDOCRINE-RELATED CANCER (2008)
Design and synthesis of bisubstrate inhibitors of type 1 17β-hydroxysteroid dehydrogenase: Overview and perspectives
D. Fournier et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
17β-hydroxysteroid dehydrogenase Type 1, and not Type 12, is a target for endocrine therapy of hormone-dependent breast cancer
Joanna M. Day et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Oestrogen producing enzymes and mammary carcinogenesis: a review
Ashok Subramanian et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Targeting cytochrome P450 enzymes: A new approach in anti-cancer drug development
Robert D. Bruno et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Overview and new strategies in metastatic breast cancer (MBC) for treatment of tamoxifen-resistant patients
V. Adamo et al.
ANNALS OF ONCOLOGY (2007)
Characterization of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β-hydroxysteroid dehydrogenase responsible for estradiol formation in women
V Luu-The et al.
MOLECULAR ENDOCRINOLOGY (2006)
Sex steroid-producing enzymes in human breast cancer
T Suzuki et al.
ENDOCRINE-RELATED CANCER (2005)
Aromatase inhibitors in the treatment of breast cancer
RW Brueggemeier et al.
ENDOCRINE REVIEWS (2005)
Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones
AH Payne et al.
ENDOCRINE REVIEWS (2004)
The proliferative effects of 5-androstene-3 beta, 17 beta-diol and 5 alpha-dihydrotestosterone on cell cycle analysis and cell proliferation in MCF7, T47D and MDAMB231 breast cancer cell lines
SR Aspinall et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2004)
Production, purification, and functional analysis of recombinant human and mouse 17β-hydroxysteroid dehydrogenase type 7
S Törn et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells
TN Mitropoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Inhibitors of 17β-hydroxysteroid dehydrogenases
D Poirier
CURRENT MEDICINAL CHEMISTRY (2003)
Involvement of up-regulation of 17β-hydroxysteroid dehydrogenase type 1 in maintenance of intratumoral high estradiol levels in postmenopausal breast cancers
Y Miyoshi et al.
INTERNATIONAL JOURNAL OF CANCER (2001)
Inhibitors of steroidogenesis as agents for the treatment of hormone-dependent cancers
HJ Smith et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2001)
分享论文
